Literature DB >> 10088138

Negative immunoregulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion.

M Maes1, C Song, A H Lin, S Bonaccorso, G Kenis, R De Jongh, E Bosmans, S Scharpé.   

Abstract

There is now some evidence that major depression is accompanied by activation of the inflammatory response system. There is also some evidence that antidepressants may suppress the release of cytokines, such as interleukin-1 beta (IL-1 beta) and IL-6 by activated monocytes and IL-2 and interferon-gamma (IFN gamma) by activated T cells. This study was carried out to examine the effects of clomipramine, sertraline, and trazodone on the stimulated production of IFN gamma, a pro-inflammatory cytokine, and IL-10, a negative immunoregulatory cytokine. Whole blood of nine healthy volunteers was stimulated with PHA, 5 micrograms/mL and LPS, 25 micrograms/mL for 72 hr with and without incubation with clomipramine, 10(-6) and 10(-9) M, sertraline, 10(-6) and 10(-8) M, and trazodone, 10(-6) and 10(-8) M. All three antidepressants significantly reduced IFN gamma secretion, whereas clomipramine and sertraline significantly increased IL-10 secretion in culture supernatant. All three antidepressants significantly reduced the IFN gamma/IL-10 ratio. The results suggest that antidepressants, at concentrations in the therapeutical range, have negative immunoregulatory effects through inhibition of IFN gamma and stimulation of IL-10 release.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10088138     DOI: 10.1016/S0893-133X(98)00088-8

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  89 in total

Review 1.  Depression in medical illness: the role of the immune system.

Authors:  R Yirmiya
Journal:  West J Med       Date:  2000-11

2.  Cellular immune activation in Gulf War veterans.

Authors:  Anna Skowera; Matthew Hotopf; Elzbieta Sawicka; Ruben Varela-Calvino; Catherine Unwin; Vasilis Nikolaou; Lisa Hull; Khalida Ismail; Anthony S David; Simon C Wessely; Mark Peakman
Journal:  J Clin Immunol       Date:  2004-01       Impact factor: 8.317

Review 3.  Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment?

Authors:  David Baumeister; Simone Ciufolini; Valeria Mondelli
Journal:  Psychopharmacology (Berl)       Date:  2015-08-14       Impact factor: 4.530

Review 4.  The Bidirectional Relationship of Depression and Inflammation: Double Trouble.

Authors:  Eléonore Beurel; Marisa Toups; Charles B Nemeroff
Journal:  Neuron       Date:  2020-06-17       Impact factor: 17.173

Review 5.  New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.

Authors:  Michael Maes; Zdenĕk Fišar; Miguel Medina; Giovanni Scapagnini; Gabriel Nowak; Michael Berk
Journal:  Inflammopharmacology       Date:  2012-01-24       Impact factor: 4.473

Review 6.  Toward Omics-Based, Systems Biomedicine, and Path and Drug Discovery Methodologies for Depression-Inflammation Research.

Authors:  Michael Maes; Gabriel Nowak; Javier R Caso; Juan Carlos Leza; Cai Song; Marta Kubera; Hans Klein; Piotr Galecki; Cristiano Noto; Enrico Glaab; Rudi Balling; Michael Berk
Journal:  Mol Neurobiol       Date:  2015-05-02       Impact factor: 5.590

7.  Immune system dysregulation in adolescent major depressive disorder.

Authors:  Vilma Gabbay; Rachel G Klein; Carmen M Alonso; James S Babb; Melissa Nishawala; Georgette De Jesus; Glenn S Hirsch; Pauline M Z Hottinger-Blanc; Charles J Gonzalez
Journal:  J Affect Disord       Date:  2008-09-13       Impact factor: 4.839

8.  Cytokine, chemokine and BDNF levels in medication-free pediatric patients with obsessive-compulsive disorder.

Authors:  Rukiye Çolak Sivri; Ayhan Bilgiç; İbrahim Kılınç
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-01-04       Impact factor: 4.785

9.  Cytokine regulation of tryptophan metabolism in the hypothalamic-pituitary-adrenal (HPA) axis: implications for protective and toxic consequences in neuroendocrine regulation.

Authors:  Huolin Tu; Peter L Rady; Terry Juelich; Eric M Smith; Stephen K Tyring; Thomas K Hughes
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

10.  Defective Inflammatory Pathways in Never-Treated Depressed Patients Are Associated with Poor Treatment Response.

Authors:  Shariful A Syed; Eléonore Beurel; David A Loewenstein; Jeffrey A Lowell; W Edward Craighead; Boadie W Dunlop; Helen S Mayberg; Firdaus Dhabhar; W Dalton Dietrich; Robert W Keane; Juan Pablo de Rivero Vaccari; Charles B Nemeroff
Journal:  Neuron       Date:  2018-08-23       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.